Finally, whilst presentation in the third trimester is uncommon with widespread use of routine second trimester anomaly scanning, targeted NIPD screening for mutations in the FGFR3 gene could readily distinguish TD from achondroplasia. The gene discussed is FGFR3; the disease is thanatophoric dysplasia.